Paul A. Monach

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

John H. Stone, Peter A. Merkel, Robert Spiera et al. · New England Journal of Medicine · 2010 · 2.7K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis

Ulrich Specks, Peter A. Merkel, Philip Seo et al. · New England Journal of Medicine · 2013 · 727 citations · Full text

Life Sciences, Immunology, Internal Medicine +12

Positive control of a global antioxidant defense regulon activated by superoxide-generating agents in Escherichia coli.

Jean T. Greenberg, Paul A. Monach, Joseph Chou et al. · Proceedings of the National Academy of Sciences · 1990 · 553 citations

Life Sciences, Genetics, Microbiology +17

A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Giant Cell Arteritis

Carol A. Langford, David Cuthbertson, Steven R. Ytterberg et al. · Arthritis & Rheumatology · 2017 · 392 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

CD4 ⁺ T cells eliminate MHC class II-negative cancer cells <i>in vivo</i> by indirect effects of IFN-γ

Dominik Mumberg, Paul A. Monach, Sherry Wanderling et al. · Proceedings of the National Academy of Sciences · 1999 · 383 citations

Life Sciences, Immunology, Oncology +17